Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Natural cancer killing cells from the human embryonic stem cells

For the first time, stem cell researchers at the University of Minnesota have coaxed human embryonic stem cells to create cancer-killing cells in the laboratory, paving the way for future treatments for various types of cancers (or tumors).

11 Oct 2005

Fear of falling gait

The patient came into the doctor's office in a wheelchair, weighted down by a diagnosis of Parkinson's disease, taking medication for the disorder and insisting she was unable to stand or walk. Thirty minutes later, after jogging down the hallway, she strolled out the door.

9 Oct 2005

Researchers have successfully combined computer modeling and experimental results in folding studies for small proteins

In unprecedented new research, scientists at Rice University have combined theory and experiment for the first time to both predict theoretically and verify experimentally the protein-folding dynamics of a large, complex protein.

3 Oct 2005

Organosilicon compounds help improve lithium battery technology

With the help of new silicon-based compounds, scientists -- and patients -- are getting a significant new charge out of the tiny lithium batteries used in implantable devices to help treat nervous system and other disorders.

3 Oct 2005

Simulator helps stroke patients learn to drive again

A high-fidelity simulator that allows people to practice driving on a computer-generated course can help stroke patients learn to drive again, researchers have found.

27 Sep 2005

Scientists reverse memory loss in mice with Alzheimer's

In mice, that had been genetically engineered to develop Alzheimer's disease, scientists were able to reverse the rodents' memory loss by reducing the amount of an enzyme that is crucial for the development of Alzheimer's disease.

26 Sep 2005

Neurologix announces positive interim results of gene therapy clinical trial for patients with Parkinson's disease

Neurologix has announced positive interim results of its landmark gene therapy clinical trial for patients with Parkinson's disease. Neurologix's 12-patient, dose-escalating Phase I trial is the world's first study to use a viral vector (the non-pathogenic adeno-associated virus, or AAV) for the treatment of an adult neurological disease.

26 Sep 2005

New information about how the brain directs the body to make movements

A University of California - San Francisco (UCSF) study has revealed new information about how the brain directs the body to make movements. The key factor is "noise" in the brain's signaling, and it helps explain why all movement is not carried out with the same level of precision.

26 Sep 2005

Parkinson's dark period can be minimized or alleviated with the right kind of care

Some people call it "the dark time," the period between when a person is diagnosed with Parkinson's disease and when treatment with medication begins.

26 Sep 2005

Botox helps explain possible causes of nerve diseases

Botox, used by Hollywood stars to smooth out facial wrinkles, is playing an important role in UQ research to understand how nerve cells communicate with each other.

22 Sep 2005

First clinical guidelines to help improve the diagnosis and treatment of people with normal pressure hydrocephalus

An international team of medical experts led by a Virginia Commonwealth University researcher has established the first clinical guidelines to help improve the diagnosis and treatment of people with normal pressure hydrocephalus, a debilitating condition in the brain that often goes undiagnosed or is misdiagnosed as Alzheimer's or Parkinson's disease.

21 Sep 2005

Key neural system at risk from prenatal exposure to alcohol

In a study of adult monkeys who were exposed to moderate amounts of alcohol in utero, scientists have found that prenatal exposure to alcohol - even in small doses - has pronounced effects on the development and function later in life of the brain's dopamine system, a critical component of the central nervous system that regulates many regions of the brain.

21 Sep 2005

Prions rapidly 'remodel' good protein into bad

Two Brown Medical School biologists have figured out the fate of healthy protein when it comes in contact with the infectious prion form in yeast: The protein converts to the prion form, rendering it infectious. In an instant, good protein goes bad.

19 Sep 2005

First large-scale whole genome map of genetic variability associated with Parkinson's disease

Mayo Clinic researchers in collaboration with scientists at Perlegen Sciences, Inc. and funded by the Michael J. Fox Foundation for Parkinson's Research have produced the first large-scale whole genome map of genetic variability associated with Parkinson's disease.

19 Sep 2005

Scientists characterize the most infectious prion protein particles

A new study of prions - apparently malformed proteins that initiate deadly brain diseases such as Creutzfeldt-Jakob disease in humans - has yielded surprising information about how the size of prions relates to their infectivity.

10 Sep 2005

Call for more donations of brains to help researchers discover new treatments for neurological disorders

Speaking at the BA Festival of Science, at Trinity College, Dublin, Dr Kirstin Goldring from Imperial College London and Charing Cross Hospital is calling for more donations of brains to help researchers discover new treatments for neurological disorders.

7 Sep 2005

Animal model of Parkinson's disease reveals striking sensitivity to common environmental toxins

In findings that support a relationship between agricultural chemicals and Parkinson's disease, two groups of researchers have found new evidence that loss of DJ-1, a gene known to be linked to inherited Parkinson's disease, leads to striking sensitivity to the herbicide paraquat and the insecticide rotenone.

7 Sep 2005

Human embryonic stem cell lines accumulate changes in their genetic material over time

The findings do not limit the utility of the cells for some types of research or for some future clinical applications, the researchers say, but draw attention to the need to closely monitor stem cell lines for genetic changes and to study how these alterations affect the cells' behavior.

6 Sep 2005

Human tissue grown from stem cells, available for transplant in the next four years

A team of researchers from the University of Liverpool in the UK have embarked on an ambitious project which could see human tissue grown from stem cells, available for transplant in the next four years.

5 Sep 2005

Human embryonic stem cell lines accumulate changes in their genetic material over time

5 Sep 2005

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Natural cancer killing cells from the human embryonic stem cells

Fear of falling gait

Researchers have successfully combined computer modeling and experimental results in folding studies for small proteins

Organosilicon compounds help improve lithium battery technology

Simulator helps stroke patients learn to drive again

Scientists reverse memory loss in mice with Alzheimer's

Neurologix announces positive interim results of gene therapy clinical trial for patients with Parkinson's disease

New information about how the brain directs the body to make movements

Parkinson's dark period can be minimized or alleviated with the right kind of care

Botox helps explain possible causes of nerve diseases

First clinical guidelines to help improve the diagnosis and treatment of people with normal pressure hydrocephalus

Key neural system at risk from prenatal exposure to alcohol

Prions rapidly 'remodel' good protein into bad

First large-scale whole genome map of genetic variability associated with Parkinson's disease

Scientists characterize the most infectious prion protein particles

Call for more donations of brains to help researchers discover new treatments for neurological disorders

Animal model of Parkinson's disease reveals striking sensitivity to common environmental toxins

Human embryonic stem cell lines accumulate changes in their genetic material over time

Human tissue grown from stem cells, available for transplant in the next four years

Human embryonic stem cell lines accumulate changes in their genetic material over time

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in